Iwona Budnicki, PhD
Iwona Budnicki, PhD
Manager, Cellular Immunology
Genovac Antibody Discovery
Patricia Odermatt
Patricia Odermatt
Research Scientist,
Single B-cell Technology

Genovac Antibody Discovery
Anupam Singhal, PhD Sr. Product Manager, Antibody Discovery Berkeley Lights
Anupam Singhal, PhD
Sr. Product Manager,
Antibody Discovery
Berkeley Lights

 

A Beacon for Rapid Antibody Discovery against Difficult Targets

Broadcast Date: November 19, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

Over the last three decades antibody therapies have been developed against a host of diseases including autoimmune disorders, infectious diseases, and cancer. Traditional technologies, however, have had limited success in delivering antibodies for difficult but highly promising targets, such as GPCRs and ion channels. In this GEN webinar, our panelists from Genovac, will present case studies of how they have overcome these antibody discovery and development challenges by leveraging their core genetic immunization technology and the Beacon optofluidic system to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species.

A live Q&A session followed the presentation, offering you a chance to pose questions to our expert panelist.


Berkeley Lights logo
 

This site uses Akismet to reduce spam. Learn how your comment data is processed.